Triple-Threat drug attack tested for tough cervical cancers
Disease control
Not yet recruiting
This study is testing a new three-drug combination as a treatment given before surgery for locally advanced cervical cancer. The goal is to see if this combination can completely eliminate the cancer from the removed tissue and is safe for patients. It will involve about 25 parti…
Phase: PHASE2 • Sponsor: Zheng Min • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC